A Study of Tirzepatide in Participants With Impaired Liver Function
Clinical trial NCT03940742 · COMPLETED
Trial details
- NCT number
- NCT03940742
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2020-09-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.